Janus Henderson Group PLC Has $131.41 Million Stock Holdings in Sotera Health Company $SHC

Janus Henderson Group PLC boosted its stake in Sotera Health Company (NASDAQ:SHC) by 35.3% in the first quarter, Holdings Channel reports. The institutional investor owned 9,162,191 shares of the company’s stock after acquiring an additional 2,390,132 shares during the quarter. Janus Henderson Group PLC’s holdings in Sotera Health were worth $131,413,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of SHC. Empowered Funds LLC increased its stake in shares of Sotera Health by 11.1% in the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock worth $332,000 after acquiring an additional 2,845 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Sotera Health by 14.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock valued at $3,999,000 after purchasing an additional 43,471 shares during the last quarter. Acadian Asset Management LLC grew its stake in Sotera Health by 125.5% in the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after purchasing an additional 14,018 shares in the last quarter. Creative Planning grew its stake in Sotera Health by 15.3% in the second quarter. Creative Planning now owns 20,186 shares of the company’s stock valued at $224,000 after purchasing an additional 2,673 shares in the last quarter. Finally, Invesco Ltd. grew its stake in Sotera Health by 4.2% in the second quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock valued at $3,549,000 after purchasing an additional 12,758 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. The Goldman Sachs Group initiated coverage on Sotera Health in a research note on Friday, June 5th. They set a “buy” rating and a $20.00 price target for the company. Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Piper Sandler reaffirmed an “overweight” rating and set a $22.00 price objective (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. UBS Group set a $19.00 target price on shares of Sotera Health in a research note on Wednesday, June 24th. Finally, Barclays lifted their target price on shares of Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Trading Up 0.1%

Sotera Health stock opened at $17.86 on Friday. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. The company has a market capitalization of $5.09 billion, a price-to-earnings ratio of 43.56 and a beta of 1.76. Sotera Health Company has a one year low of $11.00 and a one year high of $19.85. The company’s fifty day moving average price is $16.87 and its two-hundred day moving average price is $16.36.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The company had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, analysts forecast that Sotera Health Company will post 0.87 earnings per share for the current fiscal year.

Insider Buying and Selling at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 15.36% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.